Next Article in Journal
SJB2-043, a USP1 Inhibitor, Suppresses A549 Cell Proliferation, Migration, and EMT via Modulation of PI3K/AKT/mTOR, MAPK, and Wnt Signaling Pathways
Next Article in Special Issue
Correction: Knezović et al. Drug Pipeline for MASLD: What Can Be Learned from the Successful Story of Resmetirom. Curr. Issues Mol. Biol. 2025, 47, 154
Previous Article in Journal
Potential Benefits of Adding Alendronate, Celecoxib, Itraconazole, Ramelteon, and Simvastatin to Endometrial Cancer Treatment: The EC5 Regimen
 
 
Review

Article Versions Notes

Curr. Issues Mol. Biol. 2025, 47(3), 154; https://doi.org/10.3390/cimb47030154
Action Date Notes Link
article html file updated 25 November 2025 11:11 CET Update https://www.mdpi.com/1467-3045/47/3/154/html
article xml uploaded. 25 November 2025 11:10 CET Update https://www.mdpi.com/1467-3045/47/3/154/xml
article pdf uploaded. 25 November 2025 11:10 CET Updated version of record https://www.mdpi.com/1467-3045/47/3/154/pdf
Correction published 25 November 2025 00:00 CET Correction https://www.mdpi.com/1467-3045/47/12/979
article html file updated 24 June 2025 18:10 CEST Update -
article html file updated 6 March 2025 07:11 CET Update -
article pdf uploaded. 6 March 2025 07:07 CET Updated version of record https://www.mdpi.com/1467-3045/47/3/154/pdf-vor
article xml uploaded. 6 March 2025 07:07 CET Update -
article xml file uploaded 6 March 2025 07:07 CET Update -
article html file updated 27 February 2025 08:08 CET Original file -
article pdf uploaded. 27 February 2025 08:06 CET Version of Record https://www.mdpi.com/1467-3045/47/3/154/pdf-vor
article xml uploaded. 27 February 2025 08:06 CET Update -
article xml file uploaded 27 February 2025 08:06 CET Original file -
Back to TopTop